Daniel Farraye

Daniel Farraye

Goodwin

Contact
View Bio
RSS

Latest Posts › European Commission

Share:

European Commission Approves Samsung Bioepis and Biogen’s Aflibercept Biosimilar

​​​​​​​On November 18, 2024, Samsung Bioepis announced that the European Commission (EC) has approved its aflibercept biosimilar, OPUVIZ.  ...more

12/2/2024  /  Biosimilars , EU , European Commission , Pharmaceutical Industry , Prescription Drugs , Samsung Bioepis
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide